MARA Holdings Inc is not a strong buy for a beginner, long-term investor at this time. The company's financial performance is weak, with significant losses in revenue, net income, and EPS. Insider selling has increased substantially, and analysts have lowered price targets, reflecting mixed to negative sentiment. While the company is pivoting toward AI infrastructure, the transition is still in its early stages and carries risks. The technical indicators do not suggest a strong entry point, and there are no significant proprietary trading signals to support a buy decision. Given these factors, it is better to hold off on investing in MARA for now.
The MACD is positive but contracting, indicating weakening momentum. RSI is at 77.274, suggesting the stock is nearing overbought territory. Moving averages are converging, showing no clear trend. Key resistance is at 11.978, which aligns closely with the current pre-market price of 11.88, suggesting limited immediate upside.

The company is pivoting toward AI infrastructure and high-performance computing, which could be a growth area in the long term. Strategic partnerships, such as with Starwood Digital Ventures, may provide future opportunities.
Insider selling has increased by 153.70% over the last month. Analysts have lowered price targets significantly, reflecting concerns about the company's reliance on Bitcoin mining and the risks associated with its transition to AI infrastructure. Financial performance has been poor, with significant declines in revenue, net income, and EPS.
In Q4 2025, revenue dropped by 5.63% YoY to $202.31 million. Net income plummeted by 423.47% YoY to -$1.71 billion. EPS fell by 458.78% YoY to -4.7. Gross margin improved but remains negative at -105.59%. Overall, the financials indicate significant challenges.
Analysts have mixed to negative sentiment. Cantor Fitzgerald maintains an Overweight rating but has lowered the price target to $10. Clear Street and Rosenblatt have also reduced price targets. H.C. Wainwright downgraded the stock to Neutral, and Morgan Stanley initiated coverage with an Underweight rating and an $8 price target.